373 related articles for article (PubMed ID: 28720390)
41. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
[TBL] [Abstract][Full Text] [Related]
42. The chromatin modifying complex CoREST/LSD1 negatively regulates notch pathway during cerebral cortex development.
Lopez CI; Saud KE; Aguilar R; Berndt FA; Cánovas J; Montecino M; Kukuljan M
Dev Neurobiol; 2016 Dec; 76(12):1360-1373. PubMed ID: 27112428
[TBL] [Abstract][Full Text] [Related]
43. Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components.
Janzer A; Lim S; Fronhoffs F; Niazy N; Buettner R; Kirfel J
Biochem Biophys Res Commun; 2012 May; 421(4):665-70. PubMed ID: 22542627
[TBL] [Abstract][Full Text] [Related]
44. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
Laurent B; Shi Y
Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
[TBL] [Abstract][Full Text] [Related]
45. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells.
Roth M; Wang Z; Chen WY
Oncotarget; 2016 Aug; 7(31):50195-50214. PubMed ID: 27384990
[TBL] [Abstract][Full Text] [Related]
46. UTX inhibits EMT-induced breast CSC properties by epigenetic repression of EMT genes in cooperation with LSD1 and HDAC1.
Choi HJ; Park JH; Park M; Won HY; Joo HS; Lee CH; Lee JY; Kong G
EMBO Rep; 2015 Oct; 16(10):1288-98. PubMed ID: 26303947
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer.
Feng J; Xu G; Liu J; Zhang N; Li L; Ji J; Zhang J; Zhang L; Wang G; Wang X; Tan J; Huang B; Lu J; Zhang Y
Breast Cancer Res Treat; 2016 Oct; 159(3):443-56. PubMed ID: 27572339
[TBL] [Abstract][Full Text] [Related]
48. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.
Shen X; Hu K; Cheng G; Xu L; Chen Z; Du P; Zhuang Z
J Cell Biochem; 2019 Aug; 120(8):12247-12258. PubMed ID: 30864186
[TBL] [Abstract][Full Text] [Related]
49. Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A.
Cuyàs E; Gumuzio J; Lozano-Sánchez J; Carreras D; Verdura S; Llorach-Parés L; Sanchez-Martinez M; Selga E; Pérez GJ; Scornik FS; Brugada R; Bosch-Barrera J; Segura-Carretero A; Martin ÁG; Encinar JA; Menendez JA
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31331073
[TBL] [Abstract][Full Text] [Related]
50. Biological roles of LSD1 beyond its demethylase activity.
Gu F; Lin Y; Wang Z; Wu X; Ye Z; Wang Y; Lan H
Cell Mol Life Sci; 2020 Sep; 77(17):3341-3350. PubMed ID: 32193608
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
[TBL] [Abstract][Full Text] [Related]
52. LSD1: more than demethylation of histone lysine residues.
Perillo B; Tramontano A; Pezone A; Migliaccio A
Exp Mol Med; 2020 Dec; 52(12):1936-1947. PubMed ID: 33318631
[TBL] [Abstract][Full Text] [Related]
53. ERRα induces H3K9 demethylation by LSD1 to promote cell invasion.
Carnesecchi J; Forcet C; Zhang L; Tribollet V; Barenton B; Boudra R; Cerutti C; Billas IM; Sérandour AA; Carroll JS; Beaudoin C; Vanacker JM
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3909-3914. PubMed ID: 28348226
[TBL] [Abstract][Full Text] [Related]
54. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.
Kashyap V; Ahmad S; Nilsson EM; Helczynski L; Kenna S; Persson JL; Gudas LJ; Mongan NP
Mol Oncol; 2013 Jun; 7(3):555-66. PubMed ID: 23384557
[TBL] [Abstract][Full Text] [Related]
55. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
[TBL] [Abstract][Full Text] [Related]
56. LSD1 silencing inhibits the proliferation, migration, invasion, and epithelial-to-mesenchymal transition of hypopharyngeal cancer cells by inducing autophagy and pyroptosis.
Wang H; Liu F
Chin J Physiol; 2023; 66(3):162-170. PubMed ID: 37322626
[TBL] [Abstract][Full Text] [Related]
57. Lysine-Specific Demethylase 1 (LSD1) epigenetically controls osteoblast differentiation.
Rummukainen P; Tarkkonen K; Dudakovic A; Al-Majidi R; Nieminen-Pihala V; Valensisi C; Hawkins RD; van Wijnen AJ; Kiviranta R
PLoS One; 2022; 17(3):e0265027. PubMed ID: 35255108
[TBL] [Abstract][Full Text] [Related]
58. Regulation of human trophoblast syncytialization by histone demethylase LSD1.
Milano-Foster J; Ray S; Home P; Ganguly A; Bhattacharya B; Bajpai S; Pal A; Mason CW; Paul S
J Biol Chem; 2019 Nov; 294(46):17301-17313. PubMed ID: 31591264
[TBL] [Abstract][Full Text] [Related]
59. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
[TBL] [Abstract][Full Text] [Related]
60. The epigenetic promotion of osteogenic differentiation of human adipose-derived stem cells by the genetic and chemical blockade of histone demethylase LSD1.
Ge W; Liu Y; Chen T; Zhang X; Lv L; Jin C; Jiang Y; Shi L; Zhou Y
Biomaterials; 2014 Jul; 35(23):6015-25. PubMed ID: 24794925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
